MariMed Inc., a multi-state cannabis operator based in Norwood, Massachusetts, reported a total revenue of $159.8 million for the fiscal year ending December 31, 2025, reflecting a modest increase of 1.3% from $157.7 million in 2024. The growth was primarily driven by a 10.6% rise in wholesale product sales, which reached $69.6 million, while retail sales decreased by 2.5% to $89.0 million. The company experienced a net loss of $14.5 million, compared to a loss of $12.4 million in the previous year, attributed to increased costs of revenue and operating expenses.
In terms of operational changes, MariMed completed the acquisition of First State Compassion Center (FSC) in March 2025, which has since contributed to the company’s revenue. The acquisition of FSC, previously a managed services client, marked a significant strategic shift, allowing MariMed to expand its footprint in Delaware's adult-use cannabis market. The company also made two other acquisitions in 2024, enhancing its retail presence in Illinois and Maryland. As of December 31, 2025, MariMed operated 33 cannabis licenses across six states, with a focus on vertically integrated operations in Illinois, Maryland, Massachusetts, and Delaware.
The company reported a total employee headcount of 923 as of the end of 2025, an increase from the previous year, reflecting its expansion efforts. MariMed's retail operations, branded as Thrive, are recognized for their customer service and product selection, with three dispensaries in Massachusetts and two in Delaware. The company has also implemented home delivery options in Massachusetts and Delaware, with plans to expand this service to other markets as regulations permit.
Looking ahead, MariMed aims to enhance its product brand revenue by strengthening cultivation and processing capabilities, launching innovative products, and expanding its distribution network. The company is also focused on increasing retail store revenue through improved customer experiences and expanding its dispensary footprint in existing and new markets. However, the company faces challenges, including regulatory hurdles and competition from other cannabis operators, which could impact its growth strategy. MariMed continues to monitor the evolving regulatory landscape and its potential effects on operations and market conditions.
About MARIMED INC.
Marimed Inc. is a multi-state U.S. cannabis operator developing, owning, and managing licensed cultivation, production, and retail facilities. It offers proprietary brands of premium cannabis flower, concentrates, edibles, and innovative products. Serving adult-use and medical markets, it distributes wholesale and operates dispensaries, emphasizing quality, brand development, and consumer experience. Its business model combines vertical integration, brand licensing, and strategic acquisitions to drive growth and market share.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.